413 related articles for article (PubMed ID: 24004666)
21. Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome.
Parry EM; Leshchiner I; Guièze R; Johnson C; Tausch E; Parikh SA; Lemvigh C; Broséus J; Hergalant S; Messer C; Utro F; Levovitz C; Rhrissorrakrai K; Li L; Rosebrock D; Yin S; Deng S; Slowik K; Jacobs R; Huang T; Li S; Fell G; Redd R; Lin Z; Knisbacher BA; Livitz D; Schneider C; Ruthen N; Elagina L; Taylor-Weiner A; Persaud B; Martinez A; Fernandes SM; Purroy N; Anandappa AJ; Ma J; Hess J; Rassenti LZ; Kipps TJ; Jain N; Wierda W; Cymbalista F; Feugier P; Kay NE; Livak KJ; Danysh BP; Stewart C; Neuberg D; Davids MS; Brown JR; Parida L; Stilgenbauer S; Getz G; Wu CJ
Nat Med; 2023 Jan; 29(1):158-169. PubMed ID: 36624313
[TBL] [Abstract][Full Text] [Related]
22. Richter transformation of chronic lymphocytic leukemia in the era of novel agents.
Wang Y; Ding W
Clin Adv Hematol Oncol; 2020 Jun; 18(6):348-357. PubMed ID: 32649656
[TBL] [Abstract][Full Text] [Related]
23. Treatment of Richter's Syndrome.
Condoluci A; Rossi D
Curr Treat Options Oncol; 2017 Nov; 18(12):75. PubMed ID: 29159711
[TBL] [Abstract][Full Text] [Related]
24. TP53/PLCG2-mutated diffuse large B-cell lymphoma richter transformation (DLBCL-RT) of CLL with unusual CD2 and PD-1 expression.
Symes E; Wang P; Lager AM; Bishop MR; Aqil B; Venkataraman G
Leuk Lymphoma; 2022 Nov; 63(11):2735-2738. PubMed ID: 35719104
[No Abstract] [Full Text] [Related]
25. Richter syndrome: molecular insights and clinical perspectives.
Rossi D; Gaidano G
Hematol Oncol; 2009 Mar; 27(1):1-10. PubMed ID: 19206112
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcome and prognostic factors of patients with Richter syndrome: real-world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC).
Abrisqueta P; Delgado J; Alcoceba M; Oliveira AC; Loscertales J; Hernández-Rivas JA; Ferrà C; Cordoba R; Yáñez L; Medina A; Motlló C; Iacoboni G; Villacampa G; González M; Bosch F
Br J Haematol; 2020 Sep; 190(6):854-863. PubMed ID: 32519351
[TBL] [Abstract][Full Text] [Related]
27. B-cell receptor configuration and mutational analysis of patients with chronic lymphocytic leukaemia and trisomy 12 reveal recurrent molecular abnormalities.
Falisi E; Novella E; Visco C; Guercini N; Maura F; Giaretta I; Pomponi F; Nichele I; Finotto S; Montaldi A; Neri A; Rodeghiero F
Hematol Oncol; 2014 Mar; 32(1):22-30. PubMed ID: 23861036
[TBL] [Abstract][Full Text] [Related]
28. [A case of Richter syndrome transformed from chronic lymphocytic leukemia with karyotype aberration of trisomy 12].
Xu ZS; Zhang JY; Zhan R; Zheng ZH; Wu SQ; Chen ZZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):287-90. PubMed ID: 22541083
[TBL] [Abstract][Full Text] [Related]
29. Hodgkin's variant of Richter transformation in chronic lymphocytic leukemia; a retrospective study from the Israeli CLL study group.
Tadmor T; Shvidel L; Goldschmidt N; Ruchlemer R; Fineman R; Bairey O; Rahimi-Levene N; Herishanu Y; Yuklea M; Arad A; Aviv A; Polliack A
Anticancer Res; 2014 Feb; 34(2):785-90. PubMed ID: 24511013
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological Study of PD-1/PD-L1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) with Emphasis on Large B-Cell Richter Transformation.
Masoud R; Eladl AE; El-Ashwah S; Abbas A; Kandil W
Asian Pac J Cancer Prev; 2023 Dec; 24(12):4243-4252. PubMed ID: 38156860
[TBL] [Abstract][Full Text] [Related]
31. [Clonality relatedness and molecular characteristics of Richter transformation].
Sha YQ; Jiang R; Miao Y; Qiu TL; Qin SC; Qiu JY; Mi HL; Wu W; Qiao C; Wu YJ; Xia Y; Wang L; Fan L; Xu W; Li JY; Zhu HY
Zhonghua Xue Ye Xue Za Zhi; 2022 Oct; 43(10):841-847. PubMed ID: 36709198
[No Abstract] [Full Text] [Related]
32. Richter syndrome: pathogenesis and management.
Rossi D; Gaidano G
Semin Oncol; 2016 Apr; 43(2):311-9. PubMed ID: 27040710
[TBL] [Abstract][Full Text] [Related]
33. Richter syndrome epidemiology in a large population based chronic lymphocytic leukemia cohort from Norway.
Lenartova A; Randen U; Johannesen TB; Tjønnfjord GE
Cancer Epidemiol; 2019 Jun; 60():128-133. PubMed ID: 30986631
[TBL] [Abstract][Full Text] [Related]
34. Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome.
Wang Y; Sinha S; Wellik LE; Secreto CR; Rech KL; Call TG; Parikh SA; Kenderian SS; Muchtar E; Hayman SR; Koehler AB; Van Dyke DL; Leis JF; Slager SL; Dong H; Kay NE; He R; Ding W
Blood Cancer J; 2021 May; 11(5):86. PubMed ID: 33972504
[TBL] [Abstract][Full Text] [Related]
35. Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome.
Rossi D; Spina V; Cerri M; Rasi S; Deambrogi C; De Paoli L; Laurenti L; Maffei R; Forconi F; Bertoni F; Zucca E; Agostinelli C; Cabras A; Lucioni M; Martini M; Magni M; Deaglio S; Ladetto M; Nomdedeu JF; Besson C; Ramponi A; Canzonieri V; Paulli M; Marasca R; Larocca LM; Carbone A; Pileri SA; Gattei V; Gaidano G
Clin Cancer Res; 2009 Jul; 15(13):4415-22. PubMed ID: 19509140
[TBL] [Abstract][Full Text] [Related]
36. U-RT1 - A new model for Richter transformation.
Schmid T; Maier J; Martin M; Tasdogan A; Tausch E; Barth TFE; Stilgenbauer S; Bloehdorn J; Möller P; Mellert K
Neoplasia; 2021 Jan; 23(1):140-148. PubMed ID: 33316538
[TBL] [Abstract][Full Text] [Related]
37. Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemia.
García-Barchino MJ; Sarasquete ME; Panizo C; Morscio J; Martinez A; Alcoceba M; Fresquet V; Gonzalez-Farre B; Paiva B; Young KH; Robles EF; Roa S; Celay J; Larrayoz M; Rossi D; Gaidano G; Montes-Moreno S; Piris MA; Balanzategui A; Jimenez C; Rodriguez I; Calasanz MJ; Larrayoz MJ; Segura V; Garcia-Muñoz R; Rabasa MP; Yi S; Li J; Zhang M; Xu-Monette ZY; Puig-Moron N; Orfao A; Böttcher S; Hernandez-Rivas JM; Miguel JS; Prosper F; Tousseyn T; Sagaert X; Gonzalez M; Martinez-Climent JA
J Pathol; 2018 May; 245(1):61-73. PubMed ID: 29464716
[TBL] [Abstract][Full Text] [Related]
38. B-cell receptor signaling and genetic lesions in TP53 and CDKN2A/CDKN2B cooperate in Richter transformation.
Chakraborty S; Martines C; Porro F; Fortunati I; Bonato A; Dimishkovska M; Piazza S; Yadav BS; Innocenti I; Fazio R; Vaisitti T; Deaglio S; Zamò A; Dimovski AJ; Laurenti L; Efremov DG
Blood; 2021 Sep; 138(12):1053-1066. PubMed ID: 33900379
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for Richter syndrome in chronic lymphocytic leukemia.
Parikh SA; Shanafelt TD
Curr Hematol Malig Rep; 2014 Sep; 9(3):294-9. PubMed ID: 25218362
[TBL] [Abstract][Full Text] [Related]
40. Multiple cell cycle regulator alterations in Richter's transformation of chronic lymphocytic leukemia.
Cobo F; Martínez A; Pinyol M; Hernández L; Gómez M; Beá S; Esteve J; Rozman M; Bosch F; López-Guillermo A; Montserrat E; Campo E
Leukemia; 2002 Jun; 16(6):1028-34. PubMed ID: 12040434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]